David Thal has spent over 25 years in organizations such as Illumina and Agilent with key accomplishments developing software applications for clinical, research and commercial use. David’s experience includes developing applications for infusion pumps, medical imaging, cell morphology, fluorescent gel analysis, quantitative PCR, DNA microarrays and next-generation DNA sequencing.
Prior to joining BeanStock Ventures, David was involved in developing a cloud application for cancer patients to find and monitor the recruiting status of clinical trials. This application was deployed using Google Cloud Platform public cloud infrastructure and Google App Engine compute. David’s expertise in medical software product development utilizing Agile methodologies is showcased in his excellence and high-quality deliverables.
David Thal is passionate about bringing medical innovations to patients that directly elevates the quality of their lives. He earned a dual Bachelor of Arts degree in Computer Science and Quantitative Economics and Decision Sciences and later completed his coursework for a Ph.D. in Biomedical Engineering.
© 2021 BeanStock Ventures